NAME William W. Quick, MD, FACP, FACE

 

LOCATION North Charleston, South Carolina, USA

 

SUMMARY

Dr. Quick is board-certified in both internal medicine and in endocrinology and metabolism, and is a Fellow of the American College of Physicians and a Fellow of the American College of Endocrinology. He has worked in the area of pharmacovigilance for various pharmaceutical companies and a CRO from 1998 to 2013. Prior to joining the pharmaceutical industry, he served in the USPHS in Alaska, was Associate Professor of Internal Medicine at the University of South Dakota, and was in private practice of endocrinology, with an emphasis on diabetes care. He has been active in the ADA for many years, and is a Past President of the American Association of Diabetes Educators, and has been a member of DIA, AACE, the Endocrine Society, and the American College of Physicians.


He has written about diabetes on the Internet since 1995, and is the editor of a diabetes website, D-is-for-Diabetes.com and frequent contributor to the diabetes section of HealthCentral.com. He is also the volunteer webmaster for the Charleston Sail and Power Squadron, and a website advisor for Districts 5 and 7 of the United States Power Squadrons.

 

 

EDUCATION

 

1971-1972 Fellowship, Endocrinology

University of Missouri Medical Center

Columbia, MO, USA

 

1968-1971 Internship and Residency, Internal Medicine

University of Missouri Medical Center

Columbia, MO, USA

 

1968 Doctor of Medicine

State University of NY

New York, USA

 

1964 Bachelor of Arts

College of Wooster

Wooster, OH, USA

 

 

PROFESSIONAL EXPERIENCE

 

October 2012 - February 2013 Consultant

Astellas Pharma Global Development

Northbrook, IL, USA

 

June 2011 - October 2011 Vice President Drug Safety

i3 Drug Safety

Basking Ridge, NJ, USA

 

May 2010 - June 2011 Senior Medical Director & Head, Medical Safety Services

i3 Drug Safety

Basking Ridge, NJ, USA

 

2008 - May 2010 Executive Medical Director for the Americas, Endocrinology & Metabolic Disease

Medical & Scientific Affairs, i3 Research

Basking Ridge, NJ, USA

 

2007 - 2008 Senior Medical Director, Endocrinology & Metabolic Disease

Medical & Scientific Affairs, i3 Research

Basking Ridge, NJ, USA

 

2005 - 2007 Director, Global Pharmacovigilance and Head, Case Review Physicians Group - Global Pharmacovigilance

Schering-Plough Research Institute

Springfield, NJ, USA

 

2001 - 2005 Associate Director, Global Pharmacovigilance and Epidemiology

Sanofi-Aventis (formerly Aventis Pharmaceuticals)

Bridgewater, NJ, USA

 

1998 - 2001 Associate Medical Director, Drug Safety Surveillance

Pfizer Inc. (formerly Parke-Davis Pharmaceutical Research)

Ann Arbor, MI, USA

 

1997 - 1998 Medical Staff (part-time)

Missouri State Board of Registration for the Healing Arts

Jefferson City, MO, USA

 

1986 - 1998 Private Practice Physician (Endocrinology)

Midwest Diabetes Care Center

Kansas City/Independence, MO, USA

 

1985 - 1986 Private Practice Physician (Endocrinology)

Midwest Diabetes and Endocrinology Center

West Des Moines, IA, USA

 

1981 - 1985 Private Practice Physician (Endocrinology)

Downtown Yankton Medical Clinic

Yankton, SD, USA

 

1978 - 1985 Director of Medical Services (part-time)

South Dakota Human Services Center

Yankton, SD, USA

 

1978 - 1985 Associate Professor of Internal Medicine and Psychiatry (part-time)

University of South Dakota School of Medicine

Vermillion, SD, USA

 

1974 - 1981 Private Practice Physician (Internal Medicine)

Yankton Medical Clinic (formerly Yankton Clinic, PA)

Yankton, SD, USA

 

1972 - 1974 Deputy Chief of Medicine, Department of Internal Medicine

US Public Health Service, Alaska Native Medical Center

Anchorage, AK, USA

 

LICENSURE/CERTIFICATION

 

1986 to Present Medical License

State of Missouri

(Previous medical licenses in Iowa, Kansas, Nebraska, and South Dakota, all now inactive or not renewed)

 

1994 Fellow

American College of Endocrinology

 

1986, 1992, 1997 Certified Diabetes Educator

National Certification Board for Diabetes Educators

 

1977 Fellow

American College of Physicians

 

1977 Certification

Subspecialty Board on Endocrinology, Diabetes and Metabolism

American Board of Internal Medicine

 

1974 Certification

American Board of Internal Medicine

 

 

PROFESSIONAL INTERESTS

 

Diabetes Education and Diabetes Care

 

Medical Education

 

Drug Safety

 

Medical Applications of Computers

 

Recent Attendance at Professional Meetings

 

PROFESSIONAL MEMBERSHIPS

 

1991 to Present American Association of Clinical Endocrinologists

Charter Member

1979 to Present American Association of Diabetes Educators

1994 to Present American College of Endocrinology

1972 to Present American College of Physicians

1972 to Present American Diabetes Association

 

COMMUNITY SERVICE

 

2013 to Present Charleston Sail and Power Squadron

  • Webmaster, CharlestonSailandPowerSquadron website (at http://www.CharlestonSailandPowerSquadron.org)

2014 to Present United States Power Squadrons

  • Website Advisor, Districts 5 and 7 (responsible for review of approximately 23 websites)

 

ABSTRACTS

 

Quick WW, et al. Reporting Rate of Jaundice/Hyperbilirubinemia in Troglitazone Treated Patients Has Decreased. American Association of Clinical Endocrinologists, May 2000, Atlanta, GA

 

Quick WW, et al. Reporting Rate of Liver Transplant and Death with Troglitazone Has Decreased. American Diabetes Association, June 2000, San Antonio, TX

 

Huang EA, Zdon GS, Moore RJ, Moran HJ, Reidel V, Quick WW. Trends in early metformin monotherapy for newly diagnosed type 2 diabetes in the United States, 2001-2007. American Diabetes Association, June 2009, New Orleans, LA

 

 

PUBLICATIONS

 

Quick WW. Diagnosis of diabetes: use of the oral glucose tolerance test. Mo Med. 1972 Apr;69(4):275-7

 

Quick WW. Filing and retrieving medical literature. JAMA. 1979 Aug 24-31;242(8):710-1.

 

Quick WW. Pathophysiology of Diabetes. In Diabetes Education: A Core Curriculum for Health Professionals, American Association of Diabetes Educators, 1988; Second Edition, 1993

 

Zhang Y, Dall TM, Mann SE, Chen Y, Martin J, Moore V, Baldwin A, Reidel VA, Quick WW. The Economic Cost of Undiagnosed Diabetes. Population Health Management. 2009, 12(2): 95-101.

Dall TM, Mann SE, Zhang Y, Quick WW, Seifert RF, Martin, J, Huang EA, Zhang, S. Distinguishing the Economic Costs Associated with Type 1 and Type 2 Diabetes. Population Health Management. 2009, 12(2): 103-110.

Zhang Y, Dall TM, Chen Y, Baldwin A, Yang W, Mann SE, Moore V, Le Nestour E, Quick WW. Medical Cost Associated with Pre-Diabetes. Population Health Management. 2009, 12(3): 157-163.

Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, Moore V, Sahai N, Dall TM. Cost of Gestational Diabetes Mellitus in the U.S. in 2007. Population Health Management. 2009, 12(3): 165-174.

 

Huang EA, Zdon GS, Moore RJ, Moran HJ, Quick WW. The impact of publishing medical specialty society guidelines on subsequent adoption of best practices: a case study with type 2 diabetes. Int J Clin Pract. 2010, 64(5): 558-561.

 

Dall TM, Zhang Y, Chen YJ,  Quick WW,  Yang WG, Fogli J. The Economic Burden Of Diabetes. Health Affairs. 2010, 29(2): 1-7.

 

Dall TM, Venkat Narayan KM, Gillespie K, Gallo PD, Blanchard T, Solcan M, O'Grady M, Quick WW. Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Population Health Metrics. 2014, 12(12)

 

 

 

May 7, 2014